Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
about
Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular CarcinomaReceptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.Cordycepin regulates GSK-3β/β-catenin signaling in human leukemia cellsPhosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway.The interaction between ER and NFκB in resistance to endocrine therapy.Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.Glycogen synthase kinase 3 beta: can it be a target for oral cancer.FAK and p53 protein interactions.Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation.Asiatic acid, a triterpene, inhibits cell proliferation through regulating the expression of focal adhesion kinase in multiple myeloma cells.Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.The proteasome inhibitor bortezomib prevents lupus nephritis in the NZB/W F1 mouse model by preservation of glomerular and tubulointerstitial architecture.The role of phosphatase and tensin homolog deleted on chromosome 10 and focal adhesion kinase in aggressive multiple myeloma.
P2860
Q27001182-383DAFB7-C86F-4B59-8280-68871679CFAAQ33739807-8DBCBCCE-FFDC-4DF9-9A3E-93AE8BDAA81FQ34618508-41C5375D-491B-4AB1-8C85-2AFD225F3F2FQ35006305-E6A211DE-88EA-4F4A-A967-3366303CAD70Q35721747-5B33BD5B-4121-430C-8D87-9C595972DAEEQ36924406-CBA9FCE7-AB14-4DB7-B54B-16087056802BQ37578604-3800B93E-67F6-43A6-8E89-4B4C76E119D8Q37764097-042784F4-3E45-4258-B39E-C323816E1F47Q37847610-5A00C1A9-25E4-4AC7-82C3-B9CF63BCA7B8Q39389835-3E679F8B-2F8F-4D19-A624-88C3A915A074Q41080887-440F493D-1186-42D8-894F-8EF997595AE7Q41909880-9DC76C28-92BE-4329-B316-8DD05C5D59C0Q48363650-D67DAB5B-40C1-4C9B-AEC2-48166DB0EF45Q52837987-EC32F04D-E15E-4E6B-8B07-04B168DFAC9AQ53675215-7A328209-01C2-4658-ACDA-A8F2D4E64534Q54538386-DAA6881A-766B-46D7-AC40-ED206FBA33EF
P2860
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@en
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@nl
type
label
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@en
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@nl
prefLabel
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@en
Bortezomib suppresses focal ad ...... upting nuclear factor-kappa B.
@nl
P2093
P1433
P1476
Bortezomib suppresses focal ad ...... rupting nuclear factor-kappa B
@en
P2093
Cheng-Chin Kuo
Chia-Chia Liu
Chien-Hung Chen
Chung-Che Chang
Jun-Yang Liou
Tang-Long Shen
Tzu-Ching Chang
Vita M Golubovskaya
Ying-Chun Shen
P304
P356
10.1016/J.LFS.2009.12.003
P407
P577
2009-12-22T00:00:00Z